Lisa Weiss is the Senior Director of Evaluation and Surveillance and currently leads our work on Active Surveillance within the NEST initiative. Lisa brings over twenty-five years of research experience in surveillance, epidemiology and real-world evidence (RWE) across Academia, Industry, and Public Health through various positions with leading organizations and institutions such as Novartis, Pfizer, and Columbia University. Most recently, Lisa worked as a RWE and Health Outcomes Subject Matter Expert (SME) consulting to a wide range of organizations prior to joining MDIC.
Lisa is active in other organizations relevant to our work where she lends her experience to improve the use of RWE. She is a Senior Medical Affairs Fellow at HITLAB, an independent global thought leadership organization, where she advises on strategy and development of robust methodology to demonstrate effectiveness of emerging digital health technologies. She also holds leadership positions with the International Society for Pharmacoepidemiology (ISPE), The Professional Society for Health Economics and Outcomes Research (ISPOR), Women in Bio, and Healthcare Businesswomen’s Association. Lisa continues to teach research methodology and regulatory science and routinely mentors graduate students and professionals.
Lisa received a Master of Public Health (MPH) degree and a Doctor of Philosophy (PhD) in Epidemiology from Columbia University.
